// App-Quantinova.ai

458 : Characterization of HZ-G206: A potent and oral small molecule PD-L1 inhibitor

Researchers

Presenter

  • Yizhe WU

Principal Investigators

  • Xingguo Liu

  • Xinxin Jin

  • Jinglai Huang

  • Xinglu Zhou

Medical Centers

  • HangZhou HealZen, Hangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved